GlobalData on MSN6d
Egyptian Drug Authority approves Lilly and EVA’s insulin injection
Lilly has been instrumental in supplying its API for insulin at a low cost and offering technology transfer to EVA.
BioSpace1d
Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...
Eli Lilly announces regulatory approval for insulin manufactured in Egypt
The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY).
drugdeliverybusiness7d
Lilly gets nod to market locally manufactured insulin in Egypt
Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership ...
Lilly’s US weight-loss drug shortage ends, curtailing copycats
Eli Lilly and Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
Stockhouse7d
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with type 1 and type ...
Nasdaq7d
Eli Lilly announces regulatory approval for insulin manufactured in Egypt
The Egyptian Drug Authority approved the insulin ... with type 1 and type 2 diabetes in low- to middle-income countries, most of which are in Africa. Under this agreement, Lilly has been supplying ...
Lilly And EVA Pharma Announce Regulatory Approval And Release Of Locally Manufactured Insulin In Egypt
The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY ). Launched in 2022, the collaboration aims ...